Article
Evaluating the Clinical Performance of a Dual-Target Stool DNA Test for Colorectal Cancer Detection
8 Dec 2021
Abstract excerpt
The dual-target stool DNA test, iColocomf, has potential utility for colorectal cancer (CRC) detection, but its clinical accuracy has not been validated on larger groups. We therefore evaluated the performance of iColocomf in a multicenter clinical trial. In this double-blinded case-control study, 1164 participants from three independent hospitals, including 320 CRC patients, 148 adenomas, 396 interfering...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
